Virtual Cell Modeling and Novelty Analysis
Advanced virtual-cell analysis that converts disease and control omics data into cell-type-specific disease mechanisms, predicted therapeutic targets, in silico gene perturbation results, and quantitative novelty rankings.
Price
$500 / biological sample
Overview
Virtual Cell Modeling is an advanced computational analysis service designed to identify disease-driving cell states, molecular programs, intercellular signaling mechanisms, and candidate therapeutic targets from customer-provided omics data.
The service goes beyond basic differential-expression analysis. It integrates cell-state modeling, donor-aware statistical testing, pathway and regulatory-network analysis, intercellular communication, disease-state scoring, and in silico gene perturbation to determine which genes or pathways may shift diseased cells toward a healthier state.
The analysis can provide novelty results for each candidate target, including evidence strength, disease specificity, cell-type specificity, predicted therapeutic effect, reproducibility, and the extent to which the finding is supported or not previously emphasized in reference datasets and published evidence.
Included Analyses
Novelty Results Provided
For each prioritized target, the report provides:
Deliverables
Proposed Publication-Quality Figures
The report may include up to 10–15 figures depending on data quality:
Customer Data Requirements
Important Notice
The $500 price applies to each biological sample. Final analyses depend on data quality, sample number, available metadata, biological replication, and compatibility of the submitted data.
Novelty scoring represents a computational and evidence-based assessment. It does not guarantee publication, patentability, clinical effectiveness, or experimental validation. Biological conclusions should be confirmed in independent datasets and laboratory studies.
Total price is calculated as number of biological samples × $500.